Skip to main content
Fig. 3 | Molecular Cancer

Fig. 3

From: Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma

Fig. 3

Validation of SubSigLnc-17 in the subtype classification and prognosis for DLBCL patients in the internal validation cohort and entire GSE31312 cohort. ROC analysis of the sensitivity and specificity of subtype prediction by the SubSigLnc-17 in the a internal validation cohort and d entire GSE31312 cohort. Kaplan-Meier survival curves of overall survival between predicted GCB-like group and ABC-like group by SubSigLnc-17 in the b internal validation cohort and e entire GSE31312 cohort. Kaplan-Meier survival curves of progression-free survival between predicted GCB-like group and ABC-like group by SubSigLnc-17 in the c internal validation cohort and f entire GSE31312 cohort

Back to article page

Molecular Cancer

ISSN: 1476-4598